ema

The EMA does not recommend using Lekembi to slow the symptoms of Alzheimer’s disease.

The European Medicines Agency (EMA) yesterday ruled against the approval in the European Union of the drug Lekambi, designed to…

2 months ago

treatment that saves lives

The case of Didac Blasco, a nine-year-old boy from Barcelona, ​​illustrates the importance of advances in the treatment of severe…

2 months ago